These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Human Schlafen 5 (SLFN5) Is a Regulator of Motility and Invasiveness of Renal Cell Carcinoma Cells. Sassano A; Mavrommatis E; Arslan AD; Kroczynska B; Beauchamp EM; Khuon S; Chew TL; Green KJ; Munshi HG; Verma AK; Platanias LC Mol Cell Biol; 2015 Aug; 35(15):2684-98. PubMed ID: 26012550 [TBL] [Abstract][Full Text] [Related]
4. Schlafen family is a prognostic biomarker and corresponds with immune infiltration in gastric cancer. Xu J; Chen S; Liang J; Hao T; Wang H; Liu G; Jin X; Li H; Zhang J; Zhang C; He Y Front Immunol; 2022; 13():922138. PubMed ID: 36090985 [TBL] [Abstract][Full Text] [Related]
5. Comprehensive analysis of bulk and single-cell RNA sequencing data reveals Schlafen-5 (SLFN5) as a novel prognosis and immunity. Wu YJ; Chiao CC; Chuang PK; Hsieh CB; Ko CY; Ko CC; Chang CF; Chen TY; Nguyen NUN; Hsu CC; Chu TH; Fang CC; Tsai HY; Tsai HC; Anuraga G; Ta HDK; Xuan DTM; Kumar S; Dey S; Wulandari FS; Manalu RT; Ly NP; Wang CY; Lee YK Int J Med Sci; 2024; 21(12):2348-2364. PubMed ID: 39310264 [TBL] [Abstract][Full Text] [Related]
6. Expression and regulation of Schlafen (SLFN) family members in primary human monocytes, monocyte-derived dendritic cells and T cells. Puck A; Aigner R; Modak M; Cejka P; Blaas D; Stöckl J Results Immunol; 2015; 5():23-32. PubMed ID: 26623250 [TBL] [Abstract][Full Text] [Related]
7. Schlafen Family Intra-Regulation by IFN-α2 in Triple-Negative Breast Cancer. Brown SR; Vomhof-DeKrey EE; Al-Marsoummi S; Brown ND; Hermanson K; Basson MD Cancers (Basel); 2023 Nov; 15(23):. PubMed ID: 38067362 [TBL] [Abstract][Full Text] [Related]
8. Role of Schlafen 2 (SLFN2) in the generation of interferon alpha-induced growth inhibitory responses. Katsoulidis E; Carayol N; Woodard J; Konieczna I; Majchrzak-Kita B; Jordan A; Sassano A; Eklund EA; Fish EN; Platanias LC J Biol Chem; 2009 Sep; 284(37):25051-64. PubMed ID: 19592487 [TBL] [Abstract][Full Text] [Related]
9. SLFN5 suppresses cancer cell migration and invasion by inhibiting MT1-MMP expression via AKT/GSK-3β/β-catenin pathway. Wan G; Liu Y; Zhu J; Guo L; Li C; Yang Y; Gu X; Deng LL; Lu C Cell Signal; 2019 Jul; 59():1-12. PubMed ID: 30844429 [TBL] [Abstract][Full Text] [Related]
10. Human SLFN5 is a transcriptional co-repressor of STAT1-mediated interferon responses and promotes the malignant phenotype in glioblastoma. Arslan AD; Sassano A; Saleiro D; Lisowski P; Kosciuczuk EM; Fischietti M; Eckerdt F; Fish EN; Platanias LC Oncogene; 2017 Oct; 36(43):6006-6019. PubMed ID: 28671669 [TBL] [Abstract][Full Text] [Related]
11. Expression and function of hypoxia inducible factor-1 alpha in human melanoma under non-hypoxic conditions. Mills CN; Joshi SS; Niles RM Mol Cancer; 2009 Nov; 8():104. PubMed ID: 19919690 [TBL] [Abstract][Full Text] [Related]
12. STAT5 contributes to interferon resistance of melanoma cells. Wellbrock C; Weisser C; Hassel JC; Fischer P; Becker J; Vetter CS; Behrmann I; Kortylewski M; Heinrich PC; Schartl M Curr Biol; 2005 Sep; 15(18):1629-39. PubMed ID: 16169484 [TBL] [Abstract][Full Text] [Related]
13. SCHLAFEN 5 expression correlates with intestinal metaplasia that progresses to gastric cancer. Companioni Nápoles O; Tsao AC; Sanz-Anquela JM; Sala N; Bonet C; Pardo ML; Ding L; Simo O; Saqui-Salces M; Blanco VP; Gonzalez CA; Merchant JL J Gastroenterol; 2017 Jan; 52(1):39-49. PubMed ID: 27032393 [TBL] [Abstract][Full Text] [Related]
14. Downregulation of RIG-I mediated by ITGB3/c-SRC/STAT3 signaling confers resistance to interferon-α-induced apoptosis in tumor-repopulating cells of melanoma. Li Y; Song Y; Li P; Li M; Wang H; Xu T; Yu X; Yu Y; Tai Y; Chen P; Cai X; Wang X; Xiang L; Deng R; Zhang X; Gao L; Wang X; Liu J; Cao F J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32152220 [TBL] [Abstract][Full Text] [Related]
15. PAX2 regulates ADAM10 expression and mediates anchorage-independent cell growth of melanoma cells. Lee SB; Doberstein K; Baumgarten P; Wieland A; Ungerer C; Bürger C; Hardt K; Boehncke WH; Pfeilschifter J; Mihic-Probst D; Mittelbronn M; Gutwein P PLoS One; 2011; 6(8):e22312. PubMed ID: 21876729 [TBL] [Abstract][Full Text] [Related]
16. CTGF is overexpressed in malignant melanoma and promotes cell invasion and migration. Braig S; Wallner S; Junglas B; Fuchshofer R; Bosserhoff AK Br J Cancer; 2011 Jul; 105(2):231-8. PubMed ID: 21673687 [TBL] [Abstract][Full Text] [Related]
17. High density oligonucleotide array analysis of interferon- alpha2a sensitivity and transcriptional response in melanoma cells. Certa U; Seiler M; Padovan E; Spagnoli GC Br J Cancer; 2001 Jul; 85(1):107-14. PubMed ID: 11437411 [TBL] [Abstract][Full Text] [Related]
18. Circular RNA circ_0079593 enhances malignant melanoma progression by the regulation of the miR-573/ABHD2 axis. Zhao F; Jia Z; Feng Y; Li Z; Feng J J Dermatol Sci; 2021 Apr; 102(1):7-15. PubMed ID: 33648800 [TBL] [Abstract][Full Text] [Related]
19. Modulation of SOCS protein expression influences the interferon responsiveness of human melanoma cells. Lesinski GB; Zimmerer JM; Kreiner M; Trefry J; Bill MA; Young GS; Becknell B; Carson WE BMC Cancer; 2010 Apr; 10():142. PubMed ID: 20398276 [TBL] [Abstract][Full Text] [Related]
20. Overexpression of SLFN5 induced the epithelial-mesenchymal transition in human lung cancer cell line A549 through β-catenin/Snail/E-cadherin pathway. Guo L; Liu Z; Tang X Eur J Pharmacol; 2019 Nov; 862():172630. PubMed ID: 31472120 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]